A 76-year-old woman with cirrhosis has a calculated CrCl of 95 mL/min using the Cockcroft–Gault equation. Her vancomycin trough is 26 mcg/mL on q12h dosing. What explains the discrepancy?
Cirrhosis increases renal clearance of vancomycin.
Population kinetics overestimated clearance due to low muscle mass and unreliable serum creatinine in patients with cirrhosis.
The patient is clearing vancomycin faster than expected.
The trough is therapeutic for severe infections.
Two patients have the same measured creatinine clearance at baseline. One has cirrhosis. After monitoring, trough-based assessment shows higher-than-expected concentrations in the cirrhosis patient. Which scenario best explains why identical CrCl can still yield different vancomycin kinetics?
Creatinine clearance determines Ke exactly and never differs across patients
Non-renal and clinical confounders can change vancomycin processing despite similar CrCl
Levels become unnecessary once CrCl is known
The half-life formula does not use Ke-derived assumptions
A patient begins vancomycin. The first trough is drawn after several doses but the timing of administration is inconsistent (some doses were given early, some late, some on-time). Which outcome is most likely, and what is the best next step?
Trough is underestimated; keep interval unchanged without rechecking
Trough is overestimated; adjust dosing using the flawed trough immediately
Trough may be misleading; redraw/submit correctly timed levels and then calculate AUC for dosing decisions
Trough timing does not affect AUC calculations
A 58 year-old-man with MRSA endocarditis is receiving vancomycin. His AUC is calculated at 620 µg·h/mL with a trough of 17 mcg/ml. Renal function is stable. Which interpretation is most accurate?
Patient is subtherapeutic
Patient is therapeutic
Patient needs a higher dose to target a trough closer to 20 mcg/ml
Patient is above the recommended AUC range and at an increased risk of nephrotoxicity
Which statement best describes why "trough-only" monitoring for vancomycin is no longer favored.
Trough-only has a a less favorable efficacy/toxicity balance compared with AUC-based exposure monitoring
Trough monitoring requires more frequent blood draws than AUC-based monitoring.
Trough levels are only accurate in patients with renal impairment.
Trough levels consistently underestimate vancomycin concentrations in all patients.
A patient trough level for the treatment of osteomyelitis results at 18 mcg/ml. The clinical team is surprised that the dose was decreased by pharmacy. What is the most likely explanation for this change?
Dose was changed in error
Though the trough is therapeutic the calculated AUC exceeds the 600 mcg/ml, placing the patient at risk of nephrotoxicity
Pharmacy was not aware of indication
Though the trough was therapeutic the wound was showing signs of improvement thus requiring a lower dose
A paraplegic patient with low muscle mass has a calculated CrCl of 110 mL/min, but his vancomycin trough is 22 mcg/mL on q12h dosing.
Population kinetics overestimated renal clearance due to low muscle mass.
The patient is clearing vancomycin faster than expected.
The trough is therapeutic and no changes are needed.
The level is inaccurate because paraplegia prevents true trough formation.
A patient’s initial vancomycin regimen is selected using population-based kinetics. After appropriate levels are drawn, the calculated patient-specific elimination rate constant is lower than expected. What change best matches the kinetic implication of a lower Ke?
Lower Ke means longer half-life → dose should be given less frequently
Lower Ke means shorter half-life → dose should be given more frequently
Lower Ke means troughs are guaranteed therapeutic → no adjustment needed
Lower Ke affects only AUC, not dosing interval
A vancomycin level is drawn 20 minutes after the infusion is completed. The level is 36 mcg//mL. What is the best interpretation?
The level is acceptable for calculating AUC because timing does not matter
The level indicates AKI and requires immediate reduction
The level is falsely elevated due to post infusion sampling and should not be used for dosing decisions
It is a true trough because it was drawn after the infusion was completed
A patient’s vancomycin AUC is 380 mg·h/L with a trough of 11 mcg/mL. The MIC is 1.0. What is the most appropriate adjustment?
Switch to trough-only monitoring because AUC is below goal.
Maintain current regimen because the trough is above 10 mcg/mL.
Increase dose or frequency to reach an AUC of at least 400 mg·h/L.
Decrease dose because the trough is approaching nephrotoxic levels.